跳至主要内容
临床试验/JPRN-UMIN000019031
JPRN-UMIN000019031已完成未知

Efficacy and safety of dulaglutide when used instead of exenatide extended-release in type 2 diabetic patients - Efficacy and safety of dulaglutide when used instead of exenatide extended-release in type 2 diabetic patients

Haga Diabetes Clinic0 个研究点目标入组 40 人开始时间: 2015年9月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Type 1 diabetic patients. Patients with a history of severe ketosis or diabetic coma in previous 6 months. Patients with severe infection, before/after surgery or severe traumatic injury. Patients to have a plan to be pregnant. Patients with severe gastroenteric disturbance as exemplified by severe gastro-paresis. Patients with a history of pancreatitis.

研究者

发起方
Haga Diabetes Clinic

相似试验